Edinburgh Research Explorer Common variants at 10 genomic loci influence hemoglobin A(C) levels via glycemic and nonglycemic pathways

OBJECTIVE Glycated hemoglobin (HbA1c), used to monitor and diagnose diabetes, is influenced by average glycemia over a 2- to 3-month period. Genetic factors affecting expression, turnover, and abnormal glycation of hemoglobin could also be associated with increased levels of HbA1c. We aimed to identify such genetic factors and investigate the extent to which they influence diabetes classification based on HbA1c levels. RESEARCH DESIGN AND METHODS We studied associations with HbA1c in up to 46,368 nondiabetic adults of European descent from 23 genome-wide association studies (GWAS) and 8 cohorts with de novo genotyped single nucleotide polymorphisms (SNPs). We combined studies using inverse-variance meta-analysis and tested mediation by glycemia using conditional analyses. We estimated the global effect of HbA1c loci using a multilocus risk score, and used net reclassification to estimate genetic effects on diabetes screening. RESULTS Ten loci reached genome-wide significant association with HbA1c, including six new loci near FN3K (lead SNP/P value, rs1046896/P = 1.6 × 10−26), HFE (rs1800562/P = 2.6 × 10−20), TMPRSS6 (rs855791/P = 2.7 × 10−14), ANK1 (rs4737009/P = 6.1 × 10−12), SPTA1 (rs2779116/P = 2.8 × 10−9) and ATP11A/TUBGCP3 (rs7998202/P = 5.2 × 10−9), and four known HbA1c loci: HK1 (rs16926246/P = 3.1 × 10−54), MTNR1B (rs1387153/P = 4.0 × 10−11), GCK (rs1799884/P = 1.5 × 10−20) and G6PC2/ABCB11 (rs552976/P = 8.2 × 10−18). We show that associations with HbA1c are partly a function of hyperglycemia associated with 3 of the 10 loci (GCK, G6PC2 and MTNR1B). The seven nonglycemic loci accounted for a 0.19 (% HbA1c) difference between the extreme 10% tails of the risk score, and would reclassify ∼2% of a general white population screened for diabetes with HbA1c. CONCLUSIONS GWAS identified 10 genetic loci reproducibly associated with HbA1c. Six are novel and seven map to loci where rarer variants cause hereditary anemias and iron storage disorders. Common variants at these loci likely influence HbA1c levels via erythrocyte biology, and confer a small but detectable reclassification of diabetes diagnosis by HbA1c.

Christian Gieger | Nicole Soranzo | Josée Dupuis | Muredach P. Reilly | Claudia Langenberg | Inga Prokopenko | Serena Sanna | Eleanor Wheeler | Manjinder S. Sandhu | Dörte Radke | C. Gieger | W. McArdle | M. Reilly | G. Willemsen | J. Peden | S. Ripatti | M. Sandhu | K. Mohlke | B. Voight | R. Sladek | G. Rocheleau | J. Dupuis | C. Willenborg | I. Prokopenko | N. Soranzo | C. Langenberg | N. Bouatia-Naji | S. Sanna | R. Strawbridge | D. Radke | E. Wheeler | C. Lecoeur | Kuusisto | Olla | J. Devaney | M. Heeney | A. Mälarstig | Nabila Bouatia-Naji | Joseph M. Devaney | S. Ricketts | Matthew M. Heeney | Lyssenko | E. Stolerman | Elliot Stolerman | Sally L. Ricketts | Leif | Groop | S. | Meisinger | Stephen E. Epstein | Pankow | Ozren | Polašek | Felicity | Leena | Nathan | Mooser | Narisu Narisu | M. Morken | M. Sandhu | Surakka | Usala | Markku Laakso | Ruth J. F. Loos | Hugh Watkins | Kari Stefansson | Nancy L. Pedersen | Michael Stumvoll | Eleonora Porcu | Inga | Prokopenko | P. Muredach | Reilly | Knut | Krohn | Brigitte | Kühnel | Johanna | Valeriya | Ruth | McPherson | Christa | Olle Melander | E. Vincent | M. David | Chris O’Donnell | Konrad | Oexle | Nazario | James | Payne | Peltonen | Markus | Perola | Daniel J. Rader | Richa | Saxena | P. David | Strachan | Ida | Gianluca | Winkelmann | Erdmann | W. H. Kao | Caroline S. Fox | Matthias Nauck | M. McCarthy | Dawn M. Waterworth | Mark Lathrop | Jeanette | Juliane | Massimo Mangino | J. Zhao | J. Luan | Winfried März | R. Mägi

[1]  C. Gieger,et al.  Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis (vol 42, pg 579, 2010) , 2011 .

[2]  Ayellet V. Segrè,et al.  Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.

[3]  Alex Doney,et al.  Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge , 2010, Nature Genetics.

[4]  Christian Gieger,et al.  New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk , 2010, Nature Genetics.

[5]  P. Zimmet,et al.  International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.

[6]  Christian Gieger,et al.  A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium , 2009, Nature Genetics.

[7]  Christian Gieger,et al.  Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium , 2009, Nature Genetics.

[8]  P. Elliott,et al.  Genetic Variant in HK1 Is Associated With a Proanemic State and A1C but Not Other Glycemic Control–Related Traits , 2009, Diabetes.

[9]  J. Shaw,et al.  International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.

[10]  M. Laakso,et al.  Association of 18 Confirmed Susceptibility Loci for Type 2 Diabetes With Indices of Insulin Release, Proinsulin Conversion, and Insulin Sensitivity in 5,327 Nondiabetic Finnish Men , 2009, Diabetes.

[11]  Mark I McCarthy,et al.  Genome-wide association studies in type 2 diabetes , 2009, Current diabetes reports.

[12]  L. Groop,et al.  A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals , 2009, Diabetologia.

[13]  F. Brancati,et al.  Elevated A1C in Adults Without a History of Diabetes in the U.S. , 2009, Diabetes Care.

[14]  P. Elliott,et al.  A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk , 2009, Nature Genetics.

[15]  D. Altshuler,et al.  Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion , 2009, Nature Genetics.

[16]  Inês Barroso,et al.  Variants in MTNR1B influence fasting glucose levels , 2009, Nature Genetics.

[17]  N. Stefan,et al.  Polymorphisms within the Novel Type 2 Diabetes Risk Locus MTNR1B Determine β-Cell Function , 2008, PloS one.

[18]  Jerry Kaplan,et al.  The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. , 2008, Cell metabolism.

[19]  P. Ridker,et al.  Novel Association of HK1 with Glycated Hemoglobin in a Non-Diabetic Population: A Genome-Wide Evaluation of 14,618 Participants in the Women's Genome Health Study , 2008, PLoS genetics.

[20]  C. Lindsell,et al.  Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. , 2008, Blood.

[21]  M. Rieder,et al.  Common Missense Variant in the Glucokinase Regulatory Protein Gene Is Associated With Increased Plasma Triglyceride and C-Reactive Protein but Lower Fasting Glucose Concentrations , 2008, Diabetes.

[22]  D. Lawlor,et al.  Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. , 2008, The Journal of clinical investigation.

[23]  Jean Tichet,et al.  A Polymorphism Within the G6PC2 Gene Is Associated with Fasting Plasma Glucose Levels , 2008, Science.

[24]  N. Andrews,et al.  Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) , 2008, Nature Genetics.

[25]  N. Mohandas,et al.  Disorders of red cell membrane , 2008, British journal of haematology.

[26]  Peter M. Jones,et al.  Function and expression of melatonin receptors on human pancreatic islets , 2008, Journal of pineal research.

[27]  N. Andrews,et al.  The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. , 2008, Cell metabolism.

[28]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[29]  T. Nielsen,et al.  The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes , 2007, Diabetologia.

[30]  Evangelos Evangelou,et al.  Heterogeneity in Meta-Analyses of Genome-Wide Association Investigations , 2007, PloS one.

[31]  P. Donnelly,et al.  A new multipoint method for genome-wide association studies by imputation of genotypes , 2007, Nature Genetics.

[32]  Yurii S. Aulchenko,et al.  BIOINFORMATICS APPLICATIONS NOTE doi:10.1093/bioinformatics/btm108 Genetics and population analysis GenABEL: an R library for genome-wide association analysis , 2022 .

[33]  H. Dralle,et al.  Melatonin and type 2 diabetes – a possible link? * , 2007, Journal of pineal research.

[34]  D. Melzer,et al.  A common haplotype of the glucokinase gene alters fasting glucose and birth weight: association in six studies and population-genetics analyses. , 2006, American journal of human genetics.

[35]  G. Abecasis,et al.  Heritability of Cardiovascular and Personality Traits in 6,148 Sardinians , 2006, PLoS genetics.

[36]  D. Vertommen,et al.  Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites. , 2006, Diabetes & metabolism.

[37]  F. Chatonnet,et al.  Cloning and analysis of Nkx6.3 during CNS and gastrointestinal development. , 2006, Gene expression patterns : GEP.

[38]  N. Heisterkamp,et al.  Resistance to farnesyltransferase inhibitors in Bcr/Abl-positive lymphoblastic leukemia by increased expression of a novel ABC transporter homolog ATP11a. , 2005, Blood.

[39]  R. Little,et al.  Effects of hemoglobin C and S traits on glycohemoglobin measurements by eleven methods. , 2005, Clinical chemistry.

[40]  M. Olivier A haplotype map of the human genome. , 2003, Nature.

[41]  B. Szwergold,et al.  The expression of the genes for fructosamine-3-kinase and fructosamine-3-kinase-related protein appears to be constitutive and unaffected by environmental signals. , 2004, Biochemical and biophysical research communications.

[42]  N. Pørksen Early changes in beta-cell function and insulin pulsatility as predictors for type 2 diabetes. , 2002, Diabetes, nutrition & metabolism.

[43]  T. Frayling,et al.  Intrauterine hyperglycemia is associated with an earlier diagnosis of diabetes in HNF-1alpha gene mutation carriers. , 2002, Diabetes care.

[44]  F. Collard,et al.  Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes. , 2002, The Biochemical journal.

[45]  P. Wilson,et al.  A Genome-Wide Scan for Loci Linked to Plasma Levels of Glucose and HbA1c in a Community-Based Sample of Caucasian Pedigrees: The Framingham Offspring Study , 2002 .

[46]  G L Myers,et al.  The national glycohemoglobin standardization program: a five-year progress report. , 2001, Clinical chemistry.

[47]  E. Schaftingen,et al.  Conversion of a synthetic fructosamine into its 3-phospho derivative in human erythrocytes. , 2000, The Biochemical journal.

[48]  K. Roeder,et al.  Genomic Control for Association Studies , 1999, Biometrics.

[49]  Marc Montminy,et al.  Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus , 1999, Nature Genetics.

[50]  N. Nomura,et al.  Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. , 1999, DNA research : an international journal for rapid publication of reports on genes and genomes.

[51]  S. Hayette,et al.  Two distinct truncated variants of ankyrin associated with hereditary spherocytosis , 1998, American journal of hematology.

[52]  M. Corsetti,et al.  Prevalence of Genetic Hemochromatosis in a Cohort of Italian Patients with Diabetes Mellitus , 1998, Annals of Internal Medicine.

[53]  F M Matschinsky,et al.  Familial hyperinsulinism caused by an activating glucokinase mutation. , 1998, The New England journal of medicine.

[54]  S. Piomelli,et al.  Identification of the cDNA for human red blood cell-specific hexokinase isozyme. , 1997, Blood.

[55]  B. Forget,et al.  Ankyrin–1 mutations are a major cause of dominant and recessive hereditary spherocytosis , 1996, Nature Genetics.

[56]  M. Magnani,et al.  Hexokinase mutations that produce nonspherocytic hemolytic anemia. , 1995, Blood cells, molecules & diseases.

[57]  S. Reppert,et al.  Melatonin madness , 1995, Cell.

[58]  P. Hall,et al.  PREVALENCE OF GENETIC HAEMOCHROMATOSIS AMONG DIABETIC PATIENTS , 1989, The Lancet.

[59]  H. Mortensen,et al.  Glucosylation of human haemoglobin a in red blood cells studied in vitro. Kinetics of the formation and dissociation of haemoglobin A1c. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[60]  J. Akkerman,et al.  Generalized hexokinase deficiency in the blood cells of a patient with nonspherocytic hemolytic anemia. , 1983, Blood.

[61]  E. Neumann,et al.  Glycosylated hemoglobins (GHb): an index of red cell survival. , 1982, Blood.